CPD ER Anaphylaxis recognition of suitability form 2023

This statement has been prepared in response to the decision of the Australian Government Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...

Prescribing support tools and guidelines should be integral to any opioid stewardship program.

2022 ELC guidelines

PS26(A) Position statement on informed consent for anaesthesia or sedation

Research article from December 2019 Bulletin